Last updated 2026-06-18
- Raised Pre-Seed round led by AION Labs, Nov 2024
Total raised
—
Last: Undisclosed Round 2024-12
Stage
Pre-Seed
Founded
2024
Headcount
7
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
At Cellyrix, we are on a mission to introduce a new modality into cancer treatment by harnessing the power of cutting-edge technologies. Tumor heterogeneity, a fundamental aspect of cancer, lies at the heart of treatment challenges such as therapy resistance, metastasis, and relapse. Leveraging breakthroughs in single-cell sequencing and artificial intelligence, we are pioneering a novel approach to unlock insights into intra-tumor heterogeneity and develop innovative cancer treatments.
Funding history · 1 round · — total
2024-11
Pre-Seed
Undisclosed
★ AION Labs
Headcount over time
From 4 (2024-11) to 7 (2026-03) · +3 (+75%) · 5 points · source: Finder history + radar grounding
Q&A
- What is Cellyrix Therapeutics' primary mission?
- Cellyrix Therapeutics is on a mission to introduce a new modality into cancer treatment by harnessing cutting-edge technologies. They aim to unlock insights into intra-tumor heterogeneity and develop innovative cancer treatments.
- When was Cellyrix Therapeutics founded?
- Cellyrix Therapeutics was founded in December 2024.
- How many employees does Cellyrix Therapeutics currently have?
- Cellyrix Therapeutics currently has 1-10 employees.
- What is Cellyrix Therapeutics' current funding stage?
- Cellyrix Therapeutics is currently in the Pre-Seed funding stage.
- Which investor participated in Cellyrix Therapeutics' December 2024 funding round?
- AION Labs participated in Cellyrix Therapeutics' funding round in December 2024.
- What technologies does Cellyrix Therapeutics leverage in its approach?
- Cellyrix Therapeutics leverages breakthroughs in single-cell sequencing and artificial intelligence.
- What is the primary sector of Cellyrix Therapeutics?
- Cellyrix Therapeutics' primary sector is Health Tech & Life Sciences.
- Where is Cellyrix Therapeutics headquartered?
- Cellyrix Therapeutics is headquartered in Rehovot, Center District, Israel.
Team · 4
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMoleculesArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
drug-discoverycancer-therapypharmaceuticalsdrug-developmentcancerbiotechnologyartificial-intelligence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/103523835 |
Identifiers & details
| Founded | 2024-12 |
|---|---|
| Employees (exact) | 7 |
Radar intelligence
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 517076782 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2024-12-09 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 8 — shares_capital (4), annual_report (2), people (1), other (1) |
| Registered address | אופנהיימר 4 רחובות |
Recent registry events
| Date | Event |
|---|---|
| 2025-09-30 | הקצאת מניות |
| 2025-09-29 | שינוי בהרכב הון - מניות-פיצול מניה |
| 2025-11-25 | שינוי בהרכב הון - מניות-הפחתת הון מוקצה |
| 2025-11-20 | דו~ח שנתי-הוספת דירקטור |
| 2025-11-20 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2025-09-17 | העברת מניות |
| 2025-09-17 | עדכון בעלי תפקידים |
| 2025-07-14 | שינוי בתקנון |